Comprehensive monitoring of cardiac remodeling with aortic stroke volume values provided by a phase-contrast MRI sequence

Journal of Hypertension
Pierre Y MarieFaïez Zannad

Abstract

Blood pressure (BP) and its changes with antihypertensive therapy are key parameters when monitoring left ventricular (LV) remodeling. This dual cross-sectional and longitudinal MRI study aimed to determine whether this monitoring is enhanced by aortic stroke volume (SV) values provided by a phase-contrast sequence. The study involved 334 MRI examinations from 247 study participants who had no significant cardiac disease (18-85 years old, 40% with hypertension) and among whom 48 had a 2-4-year MRI follow-up. Left ventricular hypertrophy and concentric geometry were: respectively assessed according to LV mass indexed to body surface area (g/m) and mass/end-diastolic volume ratio (concentric remodeling index); and correlated with vascular parameters involving BP and the indexed SV (ml/m) determined in the ascending aorta with a phase-contrast sequence. Stroke volume was highly variable, ranging from 22 to 74 ml/m. The best cross-sectional correlates were: mean BP × SV product, reflecting cardiac work, for LV mass (r = 0.21); and mean BP/SV ratio, reflecting arterial load, for concentric geometry (r = 0.29). These two SV-derived parameters led to more than two-fold enhancements in cross-sectional predictions compared with BP param...Continue Reading

References

Sep 8, 2001·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·N G BellengerD J Pennell
May 15, 2002·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Joachim LotzMichael Galanski
Apr 12, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Denis ChemlaAlain Nitenberg
Mar 8, 2006·Hypertension·Ronald D SmithUNKNOWN Consideration of Noninvasive Hemodynamic Monitoring to Target Reduction of Blood Pressure Levels Study Group
Apr 26, 2008·American Journal of Hypertension·Luis M Ruilope, Roland E Schmieder
Jan 7, 2009·Therapeutic Advances in Cardiovascular Disease·Carlos M FerrarioDaniel L Wise
Dec 3, 2011·Journal of Hypertension·Ulf NeisiusChristian Delles
Aug 18, 2012·JACC. Cardiovascular Imaging·Anderson C ArmstrongJoão A C Lima
Oct 9, 2012·Cardiology Journal·Gerard CybulskiAnna Gąsiorowska
Mar 19, 2013·Journal of the American College of Cardiology·Ravi V ShahMichael Jerosch-Herold
Jul 30, 2014·Hypertension·Julio A ChirinosPatrick Segers

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01963221
NCT02430805

Software Mentioned

Medis
CV flow
MASS

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.